Sanofi, which previously reported slower timelines than most other drugmakers working on COVID-19 vaccines, now purports it may receive approval for two vaccines in 2021, according to STAT. Phase 1/2 ...
Announcing a new article publication for BIO Integration journal. In this article the authors Chunxiong Zheng, Mingqiang Li and Jianxun Ding from Sun Yat-sen University, Guangzhou, China and Changchun ...
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and full integration of the research services of L2P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results